{"id":29140,"date":"2020-09-22T15:05:28","date_gmt":"2020-09-22T19:05:28","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=29140"},"modified":"2020-09-22T15:07:10","modified_gmt":"2020-09-22T19:07:10","slug":"theres-a-very-good-reason-why-moderna-execs-are-dumping-their-stocks","status":"publish","type":"post","link":"https:\/\/stateofthenation.co\/?p=29140","title":{"rendered":"There&#8217;s a very good reason why Moderna execs are dumping their stocks."},"content":{"rendered":"<h1><strong>Why Are Moderna Executives Dumping Their Stock?<\/strong><\/h1>\n<p><!--more-->Analysis by Dr. Joseph Mercola<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-29153\" src=\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2020\/09\/investsq.png\" alt=\"\" width=\"300\" height=\"250\" \/><\/p>\n<div id=\"bcr_UpdPnlStory\">\n<div id=\"bcr_pnlStoryAtAGlance\" class=\"story-glance\">\n<div class=\"story-highlights\">\n<h3 id=\"expanderHead\" data-jsid=\"expanderHead\">STORY AT-A-GLANCE<\/h3>\n<div id=\"expanderContent\" data-jsid=\"expanderContent\">\n<ul>\n<li><span id=\"bcr_rptStory_cslStory_0\">Results from Moderna\u2019s Phase 1 human trial revealed the 100-mcg dose vaccine \u2014 which had a 100% side effect ratio after the second dose \u2014 is proceeding to Phase 3 trial assessment<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_1\">Moderna has no legal rights to a key patent for its vaccine delivery system. Moderna sought to invalidate the patent for lipid nanotechnology owned by Arbutus Biopharma but lost the challenge at the end of July 2020<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_2\">Executives at Moderna have cashed in stock options, raking in about $90 million in personal profits since January. Two Moderna executives have now sold off all of their stock holdings in the company, and its general counsel has sold nearly all of hers<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_3\">AstraZeneca has temporarily halted its Phase 3 vaccine trials due to \u201ca suspected serious and unexpected adverse reaction\u201d in a British participant<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_4\">AstraZeneca did not divulge the nature of the adverse reaction, but an anonymous source claims the trial participant was found to have transverse myelitis, an inflammatory condition that affects the spinal cord and is frequently triggered by viral infections<\/span><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"bodytext\" class=\"bodytextdiv\">\n<p>The U.S. Health and Human Services&#8217; Operation Warp Speed has pledged to deliver 300 million doses of a COVID-19 vaccine by 2021,<sup><span id=\"edn1\" data-hash=\"#ednref1\">1<\/span><\/sup>\u00a0if not sooner.<sup><span id=\"edn2\" data-hash=\"#ednref2\">2<\/span><\/sup>\u00a0However, developing a safe and effective vaccine normally takes years and begins with animal studies. The COVID-19 vaccines are all being rushed straight into human clinical tests, forgoing lengthy animal trials altogether.<\/p>\n<p>Such fast-tracked vaccines pose unknown risks, which are further magnified since governments are granting COVID-19 vaccine makers immunity from liability for all vaccine injuries and deaths that occur after the vaccines are recommended (or mandated) by public health officials.<sup><span id=\"edn3\" data-hash=\"#ednref3\">3<\/span><\/sup><\/p>\n<p>At the end of July 2020, AstraZeneca announced<sup><span id=\"edn4\" data-hash=\"#ednref4\">4<\/span><\/sup>\u00a0most countries it expects to supply with COVID-19 vaccine will grant the pharmaceutical company complete liability protection if people are harmed.<\/p>\n<p>In the U.S., vaccine makers already have something of a &#8220;<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2017\/04\/11\/big-pharma-immunity-against-vaccines-lawsuits.aspx\">free pass<\/a>&#8221; when it comes to vaccine injury liability and lawsuits through the National Childhood Vaccine Injury Act of 1986<sup><span id=\"edn5\" data-hash=\"#ednref5\">5<\/span><\/sup>\u00a0and the Public Readiness and Emergency Preparedness (PREP) Act, passed in 2005.<sup><span id=\"edn6\" data-hash=\"#ednref6\">6<\/span><\/sup><\/p>\n<p>The main concern is that the combination of COVID-19 vaccines being fast-tracked to market at &#8220;warp speed&#8221; with minimal testing, together with blanket liability protection against vaccine injuries could be a public health nightmare in the making.<\/p>\n<h2>Problems With Moderna\u2019s Vaccine Are Becoming Apparent<\/h2>\n<p>Early warning signs that something might be amiss have already started emerging. As detailed in \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/08\/04\/side-effects-of-fast-tracked-vaccine.aspx\">Gates Tries to Justify Side Effects of Fast-Tracked Vaccine<\/a>,\u201d results<sup><span id=\"edn7\" data-hash=\"#ednref7\">7<\/span><\/sup>\u00a0from Moderna\u2019s Phase 1 human trial revealed 100% of volunteers in the high-dose group suffered systemic side effects. Side effects included fatigue, chills, headache and myalgia (muscle pain); 21% suffered \u201cone or more severe events.\u201d<\/p>\n<p>According to Bill Gates, those side effects are largely due to the high dosages Moderna had to use in order to achieve desired antibody levels. But, if high dosages are required to create a robust-enough immune response, and higher dosages also cause systemic side effects in nearly all people, just how safe will this vaccination campaign be?<\/p>\n<aside class=\"takeaway tamiddle\">In the 20 years that vaccine makers have tried to develop a coronavirus vaccine, efforts have failed due to dangerous, many times lethal, side effects.<\/aside>\n<p>In July, it was reported<sup><span id=\"edn8\" data-hash=\"#ednref8\">8<\/span><\/sup>\u00a0that the 100-mcg dose vaccine \u2014 despite its 100% side effect ratio after the second dose \u2014 would proceed to Phase 3 trial assessment. In a May 26, 2020, article<sup><span id=\"edn9\" data-hash=\"#ednref9\">9<\/span><\/sup>\u00a0in STAT news, Ian Haydon, one of the Phase 1 study participants who suffered severe side effects requiring hospitalization, stated that while he recovered, the inoculation left him feeling \u201cas sick as he\u2019d ever felt.\u201d As noted by Robert F. Kennedy Jr.:<sup><span id=\"edn10\" data-hash=\"#ednref10\">10<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cThree of the 15 human guinea pigs in the high dose cohort (250 mcg) suffered a \u2018serious adverse event\u2019 within 43 days of receiving Moderna\u2019s jab. Moderna \u2026 acknowledged that three volunteers developed Grade 3 systemic events defined by the FDA as \u2018Preventing daily activity and requiring medical intervention.\u2019<\/em><\/p><\/blockquote>\n<blockquote><p><em>Moderna allowed only exceptionally healthy volunteers to participate in the study. A vaccine with those reaction rates could cause grave injuries in 1.5 billion humans if administered to \u2018every person on earth.\u2019 That is the threshold that Gates has established for ending the global lockdown.<\/em><\/p><\/blockquote>\n<blockquote><p><em>Moderna did not explain why it reported positive antibody tests for only eight participants. These outcomes are particularly disappointing because the most hazardous hurdle for the inoculation is still ahead; challenging participants with wild COVID infection.<\/em><\/p><\/blockquote>\n<blockquote><p><em>Past attempts at developing COVID vaccines have always faltered at this stage as both humans and animals achieved robust antibody response then sickened and died when exposed to the wild virus.\u201d<\/em><\/p><\/blockquote>\n<div class=\"productad\">\n<p>&nbsp;<\/p>\n<\/div>\n<h2>Moderna Patent Problems<\/h2>\n<p>Other signs of trouble include reports that Moderna has no legal rights to a key patent for its vaccine delivery system, and that company executives are now dumping their stocks. There are also questions emerging as to whether Moderna had some sort of foreknowledge that a coronavirus pandemic might be in the making.<\/p>\n<p>In the video above, independent journalist Ben Swann reports Moderna filed a patent amendment in March 2019, nine months before the COVID-19 pandemic started, stating there was a need for this vaccine technology out of concern for \u201creemergence or deliberate release of the SARS coronavirus.\u201d<\/p>\n<p>The amendment was done to a patent application that had been repeatedly rejected since its initial filing in 2015. The March 2019 amendment stressed the importance of obtaining this patent due to concerns of a beta coronavirus pandemic. Of all the viruses in the world, why would they suspect a coronavirus pandemic?<\/p>\n<p>In December 2019, the U.S. Patent Office issued a final rejection of Moderna\u2019s patent application, yet when the COVID-19 pandemic broke out in early 2020, Moderna was among the first to state they had the ability to address the problem.<\/p>\n<p>It wasn\u2019t until May 2020, months after it had already entered into partnership with the U.S. National Institutes of Health to develop the vaccine, that Moderna was finally issued the patent for it. And, even then, a key patent for the technology already belonged to another company. The NIH also holds many patents on the core mRNA technology used by Moderna.<\/p>\n<p>David E. Martin, Ph.D., a national intelligence analyst featured in Swann\u2019s video report, points out that even though Moderna \u201cvery clearly did not have the legal right, and they did not have the contractual rights, they didn\u2019t have the licensing rights\u201d required to enter into a federal contract, they were still somehow pushed to the front of the line by the NIH and Dr. Anthony Fauci.<\/p>\n<blockquote><p><em>\u201cThis is a situation in which the horse that was being bet on, Moderna, is actually not even qualified to run in the race,\u201d<\/em>\u00a0Martin says.<\/p><\/blockquote>\n<p>Martin goes on to explain how both Moderna and the NIH are essentially engaged in patent infringement, as a core part of the technology \u2014 the lipid nanoparticle technology that is part of the vaccine delivery system \u2014 belongs to another company.<\/p>\n<p>Moderna sought to invalidate the patent owned by Arbutus Biopharma, but lost the challenge at the end of July 2020.<sup><span id=\"edn11\" data-hash=\"#ednref11\">11<\/span>,<\/sup><sup><span id=\"edn12\" data-hash=\"#ednref12\">12<\/span><\/sup>\u00a0As a result, Arbutus might be able to make a royalty claim in the vaccine, and news of the failed patent challenge caused Moderna\u2019s stock to drop by 9.5%.<sup><span id=\"edn13\" data-hash=\"#ednref13\">13<\/span><\/sup><\/p>\n<h2>Moderna Executives Have Raked in Millions on Dumped Stocks<\/h2>\n<p>As reported by NPR<sup><span id=\"edn14\" data-hash=\"#ednref14\">14<\/span><\/sup>\u00a0September 4, 2020, executives at Moderna have also cashed in stock options,\u00a0<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/06\/23\/moderna-vaccine-coronavirus.aspx\">raking in tens of millions of dollars of personal profit<\/a>\u00a0in the process. Considering the patent problems now emerging and the lingering safety and efficacy questions, this move has raised significant concerns among financial experts:<\/p>\n<blockquote><p><em>\u201c\u2019On a scale of one to 10, one being less concerned and 10 being the most concerned,\u2019 said Daniel Taylor, an associate professor of accounting at the Wharton School, \u2018this is an 11.\u2019 Taylor said Moderna&#8217;s stock-selling practices appear well outside the norm, and raise questions about the company&#8217;s internal controls to prevent insider trading.<\/em><\/p><\/blockquote>\n<blockquote><p><em>Since January, CEO St\u00e9phane Bancel has sold roughly $40 million worth of Moderna stock held by himself or associated investment funds; Chief Medical Officer Tal Zaks has sold around $60 million; and President Stephen Hoge has sold more than $10 million \u2026<\/em><\/p><\/blockquote>\n<blockquote><p><em>Advocates have questioned whether it&#8217;s appropriate for executives to privately profit before bringing the vaccine to market, especially when American taxpayers have committed roughly $2.5 billion to the company&#8217;s vaccine development and manufacture.\u201d<\/em><\/p><\/blockquote>\n<p>Importantly, NPR discovered that several of the executives appear to have made \u201cquestionable modifications to stock sale plans\u201d shortly before key announcements were made about the vaccine \u2014 in some cases just a single day ahead of the announcements.<\/p>\n<p>In order to be legal, prescheduled stock sale plans must be made at a time when no confidential inside information is available that may influence their sales decisions, so the timing of their modifications appears suspicious.<\/p>\n<p>What\u2019s more, as a general rule, corporate best practices call for leadership to maintain stock in the company to ensure they have sufficient incentive to improve company performance. Two Moderna executives, however, have sold all of their stock holdings, and its general counsel has sold \u201cnearly all\u201d of hers, NPR reports.<sup><span id=\"edn15\" data-hash=\"#ednref15\">15<\/span><\/sup><\/p>\n<h2>What Do Moderna Execs Know That We Don\u2019t?<\/h2>\n<p>Why would executives unload their stocks before the vaccine is even launched? Do they suspect or know something has, or is about to go awry? As of right now, there\u2019s no evidence whatsoever that the company\u2019s novel vaccine will actually work, let alone be safe. According to NPR:<sup><span id=\"edn16\" data-hash=\"#ednref16\">16<\/span><\/sup><\/p>\n<blockquote><p><em>&#8220;Friday, March 13, three Moderna executives adopted new 10b5-1 plans, according to records reviewed by NPR: Zaks, Chief Technical Operations and Quality Officer Juan Andres, and then-Chief Financial Officer Lorence H. Kim \u2026\u00a0<\/em><\/p><\/blockquote>\n<blockquote><p><em>On Monday, March 16 \u2014 one business day later \u2014 the company announced that it had given a participant the first dose of their vaccine as part of its phase 1 trial. The stock ended that day up 24% compared to the previous day&#8217;s close \u2026<\/em><\/p><\/blockquote>\n<blockquote><p><em>\u2019Every company and individual is entitled to the presumption of innocence. That said, from the public&#8217;s perspective, this trading behavior looks very problematic,\u2019 said Taylor \u2026 who first pointed out the timing of these changes to NPR.<\/em><\/p><\/blockquote>\n<blockquote><p><em>\u2018If I put on my SEC enforcement hat, I would certainly be asking, &#8216;What caused you to change the plan on a Friday?&#8217;\u2019 said Kurt Wolfe, who works as a defense attorney in securities cases for the firm Troutman Pepper. \u2018I don&#8217;t think it&#8217;s a good fact pattern.\u2019&#8221;<\/em><\/p><\/blockquote>\n<h2>Coronavirus Vaccines Have Never Been Successfully Made<\/h2>\n<p>As I\u2019ve discussed in several previous articles, COVID-19 vaccine manufacturers have several hurdles to overcome, as\u00a0<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/06\/02\/expect-coronavirus-vaccine-failure-and-reactions.aspx\">coronavirus vaccine development has been notoriously challenging<\/a>. In the 20 years that vaccine makers have tried to develop a coronavirus vaccine, efforts have failed due to dangerous, many times lethal, side effects.<\/p>\n<p>Adding to the problem is that many of them are relying on novel mRNA technology that has never been used in vaccines before.<sup><span id=\"edn17\" data-hash=\"#ednref17\">17<\/span><\/sup>\u00a0Making matters even worse, the vaccines are not safety tested against inert placebo, as is the gold standard for drug safety research. Oxford University\u2019s mRNA vaccine, ChAdOx1 nCoV-19, for example, is being compared to a meningitis vaccine.<sup><span id=\"edn18\" data-hash=\"#ednref18\">18<\/span><\/sup><\/p>\n<p>As discussed in \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/03\/03\/placebos-may-contain-harmful-ingredients.aspx\">Dangerous Placebos Used in Medical Trials<\/a>,\u201d using an active substance such as another vaccine destroys any hope of a valid safety study. This is just one way in which vaccine makers cheat in their safety studies to minimize the appearance of adverse effects.<\/p>\n<p>In the case of a COVID-19 vaccine, establishing safety is of utmost importance, as previous coronavirus vaccines have caused paradoxical immune enhancement \u2014 a situation in which the vaccine actually makes you more susceptible to severe illness and death once you\u2019re infected with the actual virus.<\/p>\n<p>Kennedy explained this in my interview with him, featured in \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/05\/31\/is-there-a-vaccine-for-coronavirus.aspx\">Robert F. Kennedy Jr. Explains Well-Known Hazards of Coronavirus Vaccines<\/a>.\u201d A short clip of that interview is included below.<\/p>\n<div class=\"video-rwd has-figcaption\">\n<figure class=\"op-interactive aspect-ratio\"><iframe loading=\"lazy\" id=\"iFrameResizer0\" class=\" mlazyloaded\" src=\"https:\/\/www.bitchute.com\/embed\/S2714ylczhMl\/\" width=\"640\" height=\"360\" frameborder=\"0\" scrolling=\"no\" data-mlazyload-src=\"https:\/\/www.bitchute.com\/embed\/S2714ylczhMl\/\" data-mce-fragment=\"1\"><\/iframe><figcaption class=\"op-large op-center\"><a href=\"https:\/\/mercola.fileburst.com\/PDF\/ExpertInterviewTranscripts\/Interview-RobertFKennedyJr-PossibleChallengesinCoronavirusVaccineDevelopment.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Download Interview Transcript<\/a><\/figcaption><\/figure>\n<\/div>\n<p>Aside from the possibility of a paradoxical immune response, mRNA vaccines may in and of themselves be problematic. According to researchers at the University of Pennsylvania and Duke University:<sup><span id=\"edn19\" data-hash=\"#ednref19\">19<\/span>,<\/sup><sup><span id=\"edn20\" data-hash=\"#ednref20\">20<\/span><\/sup><\/p>\n<blockquote><p><em>\u201c<\/em><em>mRNA vaccines have potential safety issues, including local and systemic inflammation and stimulation of auto-reactive antibodies and autoimmunity, as well as development of edema (swelling) and blood clots.\u201d<\/em><\/p><\/blockquote>\n<h2>AstraZeneca Stopped Its Vaccine Trial Due to Side Effects<\/h2>\n<p>September 8, 2020, STAT News reported<sup><span id=\"edn21\" data-hash=\"#ednref21\">21<\/span><\/sup>\u00a0that AstraZeneca has temporarily halted its Phase 3 vaccine trials due to \u201ca suspected serious and unexpected adverse reaction\u201d in a British participant.<\/p>\n<p>The company did not divulge the nature of the adverse reaction. The New York Times claims<sup><span id=\"edn22\" data-hash=\"#ednref22\">22<\/span><\/sup>\u00a0\u201ca person familiar with the situation, and who spoke on the condition of anonymity\u201d said the individual \u201dhad been found to have transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often sparked by viral infections.\u201d<\/p>\n<p>AstraZeneca, in collaboration with the University of Oxford, is conducting Phase 2\/3 trials for their mRNA COVID-19 vaccine (ChAdOx1 nCoV-19, a chimpanzee adenovirus modified to carry and deliver coronavirus genes into human cells) in the U.K. and India, as well as Phase 3 trials in Brazil, South Africa and the U.S.<sup><span id=\"edn23\" data-hash=\"#ednref23\">23<\/span><\/sup>\u00a0According to STAT News:<sup><span id=\"edn24\" data-hash=\"#ednref24\">24<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cThe [AstraZeneca] spokesperson described the pause as \u2018a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.\u2019 The spokesperson also said that the company is \u2018working to expedite the review of the single event to minimize any potential impact on the trial timeline.\u2019\u201d<\/em><\/p><\/blockquote>\n<h2>AstraZeneca Vaccine Has High Rates of Side Effects Too<\/h2>\n<p>Like the Moderna vaccine, the AstraZeneca\/Oxford University vaccine also appears to come with a shockingly high rate of side effects. Results<sup><span id=\"edn25\" data-hash=\"#ednref25\">25<\/span><\/sup>\u00a0from one of its Phase 1\/2 studies published August 15, 2020, revealed a clear majority of participants experienced side effects. Results showed:<sup><span id=\"edn26\" data-hash=\"#ednref26\">26<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cFatigue and headache were the most commonly reported systemic reactions. Fatigue was reported in the ChAdOx1 nCoV-19 group by 340 (70%) participants without paracetamol and 40 (71%) with paracetamol \u2026<\/em><\/p><\/blockquote>\n<blockquote><p><em>Headaches were reported in the ChAdOx1 nCoV-19 group by 331 (68%) participants without paracetamol and 34 (61%) with paracetamol \u2026 Other systemic adverse reactions were common in the ChAdOx1 nCoV-19 group:<\/em><\/p><\/blockquote>\n<div class=\"indent\">\n<ul>\n<li><em>muscle ache (294 [60%] participants without paracetamol and 27 [48%] with paracetamol)<\/em><\/li>\n<li><em>malaise (296 [61%] and 27 [48%])<\/em><\/li>\n<li><em>chills (272 [56%] and 15 [27%])<\/em><\/li>\n<li><em>feeling feverish (250 [51%] and 20 [36%]). In the of ChAdOx1 nCoV-19 group, 87 (18%) participants without paracetamol and nine (16%) participants with paracetamol reported a temperature of at least 38\u00b0C, and eight (2%) patients without paracetamol had a temperature of at least 39\u00b0C\u201d<\/em><\/li>\n<\/ul>\n<\/div>\n<h2>Prepare by Attending NVIC Online Conference in October<\/h2>\n<p>If you\u2019re concerned about the possibility of COVID-19 vaccine mandates, be sure to attend the Fifth International Public Conference on Vaccination sponsored by the National Vaccine Information Center (NVIC) \u2014 an online event held October 16 through 18, 2020.<\/p>\n<p>This year\u2019s theme is \u201cProtecting Health and Autonomy in the 21st Century.\u201d The conference will bring together well-known speakers from around the world \u2014 including yours truly \u2014 who will present information on vaccine science, policy, law, ethics and civil liberties and will feature formal presentations, panel discussions and live chat rooms.<\/p>\n<p>NVIC has held four previous hotel-based conferences in the Washington, D.C., area but, this time around, the conference will be held online due to the unpredictability of government regulations related to COVID-19, including travel and social distancing restrictions that may still be in play in October.<\/p>\n<p>Also, sign up for the NVIC Advocacy Portal. It\u2019s a free service that will keep you informed and up-to-date about proposed vaccine-related legislation happening in your state that could further restrict or eliminate your legal right to make voluntary vaccine decisions for yourself and your children.<\/p>\n<\/div>\n<h2>Help Support Vaccine Awareness Week<\/h2>\n<p>The Tenth Annual Vaccine Awareness Week from September 20-26, 2020 will feature important information about vaccine science, policy and law that you can share with your family and friends.<\/p>\n<p>With aggressive efforts by pharmaceutical companies, medical trade groups and government to restrict or eliminate all personal belief vaccine exemptions and severely restrict medical exemptions in the U.S., it is critical for you to act now to protect your legal right to make informed, voluntary vaccine choices.<\/p>\n<p>Thankfully, the non-profit\u00a0<a href=\"https:\/\/www.nvic.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">National Vaccine Information Center<\/a>\u00a0(NVIC) provides the public with independent, well-referenced information on vaccines and advocates for vaccine safety and informed consent protections in the public health system. This educational charity&#8217;s mission since 1982 has been to prevent vaccine injuries and deaths through public education and to secure and defend your legal right to exercise voluntary, informed consent to vaccination.<\/p>\n<p>This year, NVIC is sponsoring the Fifth International Public Conference on Vaccination: Protecting Health &amp; Autonomy in the 21st Century online Oct. 16-18, 2020. You won&#8217;t want to miss it \u2013 register\u00a0<a href=\"https:\/\/www.eventbank.com\/event\/protecting-health-and-autonomy-in-the-21st-century-20563\/home.html\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>\u00a0today.<\/p>\n<h2>Resources Where You Can Learn More<\/h2>\n<ul>\n<li><a href=\"https:\/\/nvicadvocacy.org\/members\/Home.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">NVIC Advocacy Portal<\/a>\u00a0\u2014 Become a registered user of this unique free online communications network that electronically connects you directly with your own legislators and emails you action alerts with talking points so you can be an effective vaccine choice advocate in your state.You can use it to inform your legislators about why it is necessary to protect vaccine exemptions and your legal right to make voluntary vaccine decisions for yourself and your children.<\/li>\n<li><a href=\"https:\/\/www.nvic.org\/vaccine-information-kiosk.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">Ask 8 Vaccine Information Kiosk<\/a>\u00a0\u2014 Download brochures and reports on vaccination and how to recognize vaccine reaction symptoms, as well as posters and web badges that you can share with your family and friends. Access the illustrated and fully referenced Guide to Reforming Vaccine Policy &amp; Law to educate your legislator when you advocate for vaccine informed consent rights.<\/li>\n<li><a href=\"https:\/\/www.nvic.org\/Vaccine-Laws\/state-vaccine-requirements.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">State Law &amp; Vaccine Requirements<\/a>\u00a0\u2014 You can easily obtain your state\u2019s current vaccine policies and laws here.<\/li>\n<li><a href=\"https:\/\/www.nvic.org\/reporting-systems.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">Vaccine Reaction and Harassment Reporting<\/a>\u00a0\u2014 Search for and read descriptions of vaccine reaction reports made to the federal vaccine adverse events reporting system (VAERS). On NVIC\u2019s website, read about or publicly report a vaccine reaction or describe an experience of being bullied and sanctioned for attempting to exercise informed consent to vaccination for yourself or your child.<\/li>\n<li><a href=\"http:\/\/mercola.fileburst.com\/PDF\/Mini-Guide-to-Flu-&amp;-Flu-Vaccines.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Guide to Flu &amp; Flu Vaccines<\/a>\u00a0\u2014 This Mini Guide to influenza &amp; Flu Vaccines is a brief summary of facts about influenza and influenza vaccines.<\/li>\n<\/ul>\n<h2>Let&#8217;s Help Make NVIC\u2019s October 2020 Online Vaccine Conference A Big Success<\/h2>\n<div class=\"video-rwd\">\n<figure class=\"op-interactive aspect-ratio\"><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/bETf2Zh_i6U\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\" data-mce-fragment=\"1\"><\/iframe><\/figure>\n<\/div>\n<p>October 16-18, 2020, NVIC is sponsoring the Fifth International Public Conference on Vaccination: Protecting Health &amp; Autonomy in the 21st Century online. More than 40 distinguished speakers \u2013 including Dr. Joe Mercola \u2013 will be presenting critical information and perspective about vaccination, health and autonomy that you can use to protect your health freedom rights in 2021. This will be an historic conference that you can\u2019t afford to miss!<\/p>\n<h2>Sponsor NVIC\u2019s Pioneering Work<\/h2>\n<p>Please support NVIC\u2019s pioneering work to protect the right to know and freedom to make voluntary vaccination decisions. Become a conference Starfish Sponsor for $250 or more and help NVIC keep the $80 general ticket price low so many more people, especially families struggling with financial challenges this year, can attend and have permanent access to the online conference information.<\/p>\n<p>Give NVIC your vote of confidence to continue their four-decade life-saving mission to prevent vaccine injuries and deaths through public education and preserve health freedom.\u00a0<strong>Register\u00a0<a href=\"https:\/\/www.eventbank.com\/event\/protecting-health-and-autonomy-in-the-21st-century-20563\/\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>\u00a0to attend NVIC&#8217;s October 16-18, 2020 online Fifth International Public Conference on Vaccination: &#8220;Protecting Health &amp; Autonomy in the 21st Century.&#8221;<\/strong><\/p>\n<p><a href=\"https:\/\/www.nvic.org\/\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" src=\"https:\/\/media.mercola.com\/assets\/images\/vaccine-awareness\/nvic-logo-en.jpg\" alt=\"\" \/><\/a><\/p>\n<p>___<br \/>\n<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/09\/21\/coronavirus-vaccine-patent.aspx?cid_source=dnl&amp;cid_medium=email&amp;cid_content=art1ReadMore&amp;cid=20200921Z1&amp;mid=DM660562&amp;rid=969568399\">https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/09\/21\/coronavirus-vaccine-patent.aspx?cid_source=dnl&amp;cid_medium=email&amp;cid_content=art1ReadMore&amp;cid=20200921Z1&amp;<br \/>\nmid=DM660562&amp;rid=969568399<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Why Are Moderna Executives Dumping Their Stock?<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-29140","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/29140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=29140"}],"version-history":[{"count":0,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/29140\/revisions"}],"wp:attachment":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=29140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=29140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=29140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}